Cardlytics Non Current Liabilities Total from 2010 to 2024

CDLX Stock  USD 9.24  0.50  5.13%   
Cardlytics Non Current Liabilities Total yearly trend continues to be fairly stable with very little volatility. Non Current Liabilities Total will likely drop to about 206.5 M in 2024. During the period from 2010 to 2024, Cardlytics Non Current Liabilities Total regression line of annual values had r-squared of  0.03 and arithmetic mean of  185,484,441. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2016-12-31
Previous Quarter
268.2 M
Current Value
267.3 M
Quarterly Volatility
106.2 M
 
Covid
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.4 M or Depreciation And Amortization of 16.8 M, as well as many indicators such as Price To Sales Ratio of 1.03, Dividend Yield of 0.0 or PTB Ratio of 3.76. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
  
Check out the analysis of Cardlytics Correlation against competitors.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Latest Cardlytics' Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of Cardlytics over the last few years. It is Cardlytics' Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardlytics' overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Pretty Stable
   Non Current Liabilities Total   
       Timeline  

Cardlytics Non Current Liabilities Total Regression Statistics

Arithmetic Mean185,484,441
Geometric Mean140,637,783
Coefficient Of Variation40.26
Mean Deviation49,286,663
Median177,188,000
Standard Deviation74,675,584
Sample Variance5576.4T
Range265.6M
R-Value0.16
Mean Square Error5850.7T
R-Squared0.03
Significance0.57
Slope2,680,437
Total Sum of Squares78070.2T

Cardlytics Non Current Liabilities Total History

2024206.5 M
2023268.2 M
2022230.7 M
2021245.7 M
2020184.1 M
20192.6 M
201849.9 M

About Cardlytics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Cardlytics income statement, its balance sheet, and the statement of cash flows. Cardlytics investors use historical funamental indicators, such as Cardlytics's Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Although Cardlytics investors may use each financial statement separately, they are all related. The changes in Cardlytics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cardlytics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cardlytics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cardlytics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Liabilities Total268.2 M206.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.